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Abstract: 
A recent trend has seen U.S. pharmaceutical companies flocking to Ireland. The main motivation 
has been called a tax inversion, where the company will relocate to another country with lower tax rates 
in order to save money. The United States government has become very concerned over the lost 
revenue from these companies. This paper looks further into the motivation behind inversion and what 
drives a company beyond the tax implication to engage in an inversion. The four drivers in this paper are 
revenue structures, industry origins, ownership structure and legal factors. This is addressed through a 
case study which examines the drivers by comparing the pharmaceutical industry to the software 
industry. Through evaluation of the case study, ownership structure, revenue structure and industry 
origins are all found to have an impact of the firm’s decision while legal factors do not. Future research 
can be expanded to other industries that may have similar characteristics to the pharmaceutical industry 
in order to examine potential companies that may want to engage in an inversion.  
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1.1 Introduction 
At the forefront of international finance and tax for the last couple of years has been the wave of tax 
inversions. From Burger King to Medtronic, companies all over the United States across a variety of 
industries have found ways to save money on tax expenses.  The most publicized way recently has been 
through the use of tax inversions. Tax inversions have been used since for over 30 years as a way for 
companies to relocate its headquarters in an effort to reduce effective tax rates and save money of tax 
expenses. Though companies may publicize the relocation is done for a variety of benefits, most experts 
believe that tax incentives are the main motivation. After a wave of companies moving overseas, the 
United States government has started to crack down. A recent series of tax regulations have been 
published by the United States department of treasury in order to try and stymie the trend, which has 
seen six large pharmaceutical companies leave the United States for Ireland. These six companies have a 
combined revenue of $34.5 billion dollars that the United States government no longer has the 
opportunity to tax (Douglas-Gabriel). Companies in all industries from engineering to manufacturing 
have historically engaged in inversions, but the large majority of deals have recently been within the 
pharmaceutical industry; the question then arises why the pharmaceutical industry is moving more 
often than any other industry. 
 This thesis dives deeper into this question and look at tax inversions on the industry level. 
Research in the past has been aimed at looking at solely the tax benefits of inversions, but this paper will 
look at drivers that may also be making an inversion a more favorable practice. This paper identifies 
revenue structures, industry origins, ownership structure and finally legal implications as potential 
drivers and examines them to see which aspects of the industry are making inversions popular. By 
comparing a variety of data from a wide range of sources, this paper begins to shine light on the 
motivations behind inversions. 
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 This topic is important to a few different parties. The most publicized party is the United States 
government. Even though the money lost through inversions in regards to tax revenue has been small in 
comparison to total tax income, companies leaving the country can hurt a government in many different 
ways. These companies strengthen the economy through offering work, paying taxes, and many times 
support the community. In addition, if a company sees other companies leaving the country, they may 
be less inclined to move any operations to the United States. This loss of business may be portrayed as a 
potential sign of weakness for other corporations around the world or to startup companies. The 
government’s concern is apparent in the media and through legislation. Just last year, the Obama 
administration passed a series of legislation that not only makes inversions more difficult to complete, 
but also heavily reduces the financial incentives. If other industries begin to see the benefits of an 
inversion and believe they can be successful, they may follow suit, a trend the United States government 
would not like to see. This paper aims to identify characteristics of companies that could be potentially 
benefitted through a tax inversion. While recently pharmaceutical companies have been leading the 
way, this paper aims to draw attention to aspects of the industry that have made inversions such a 
popular choice for companies within the industry. These conclusions can be expanded to other 
industries.  
 In addition to the government, these results could have potential insight for companies looking 
to find additional ways to save money. A tax inversion can be costly, but with the right benefits, can also 
save a company a lot of money of tax expenses. Through analysis of different characteristics, this paper 
aims to identify potential patterns in companies who have successfully completed a tax inversion. If a 
company has similar characteristics to the ones identified in this study, there may be an opportunity for 
a beneficial inversion deal.  
 The literature review in this paper aims to look at what an inversion is and the motivation for 
inverting. After briefly examining the basic mechanics of the inversion, it will provide a framework for 
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the tax implications of inversions and will look more closely at the different tax systems and what about 
these systems create differences in the expenses a company must pay. The paper will then focus on a 
case study in order to look more closely into why this has become such a popular trend within the 
pharmaceutical industry. The study will look at the software industry as a comparable industry and then 
will examine the differences among the two industries which may make inversions more popular in one 
industry over another.  
 My hypothesis is that even though the software and pharmaceutical industries are similar in 
their globalization and their profit margins, there are differences in revenue structure, ownership 
structure, the industry origins, and legal implications which make companies within the pharmaceutical 
industry more likely to perform an inversion. The case study will reveal a level of importance across all of 
these drivers in order to point out those that may be having more of an affect than others.  
 The following sections all aim to support the main question. Section 2 of this paper highlights 
previous literature. Section 3 looks into the methodology behind the paper, the justification for the 
factors and industries selected, and highlights the data collected. Section 4 presents the data and finally 
section 5 gives an overview of the results found from the case study. 
2 Background of Inversions 
History of Inversions  
 The first deal that is today recognized as a tax inversion occurred in 1983 when McDermott 
Engineering reincorporated to Panama. McDermott created a subsidiary in Panama and then had the 
subsidiary take over the parent company in the United States. The government then set up tax laws to 
hinder smaller companies from taking over larger U.S. companies, such as the deal McDermott 
successfully completed. Though the government made changes, this did not stop inversions. For the first 
20 years of inversions, the Caribbean Islands and Central America were the main destinations of many 
5 
 
companies engaging in inversions, with Bermuda being by far the most popular destination. The 
majority of these companies were either Oil and Gas companies or insurance companies. Since around 
2005, a wider array of companies in varying industries have left the United States for various countries. 
There was no real trend until around 2012, when a large amount of pharmaceuticals left the United 
States for Ireland (Douglas-Gabriel). 
Mechanics of Inversions 
 The U.S. Department of Treasury has been called into action as of late into the topic of 
inversions. Due to the recent rise is an inversion as a business decision, the Treasury has had recent 
decisions about inversions, including a definition of what the United States government defines as a tax 
inversion. “A corporate inversion is transaction in which a U.S. based multinational restructures so that 
the U.S. parent is replaced by a foreign parent, in order to avoid U.S. taxes”(United States Government).  
There are many ways that a company can restructure in order to become part of a foreign parent. The 
most common way that such a transaction will take place is through a stock inversion, where the 
company in the United States will purchase enough shares of a company to form a subsidiary in another 
country. Then, owners of the parent company will trade their stock of the parent stock for stock of the 
newly formed subsidiary. The company then changes the U.S. company to a subsidiary of the company 
overseas which becomes the parent company (Desai, Hines, 8-9). This transaction may also occur with 
assets, in which the newly formed subsidiary will purchase the assets of the U.S. company in order to 
take control and make the U.S. company a subsidiary, thus changing the domiciled headquarters of the 
company. The following table, Inversion Example, illustrates in a very simple way how an inversion 
works.  
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Inversion Example (Desai, Hines, 29)  
 
  
 
 
 In this example, the U.S. parent creates a new subsidiary (Bermuda Co). Following the inversion, 
Bermuda Co. becomes the parent company and the original U.S. parent company becomes a new 
subsidiary of Bermuda following the inversion transaction. When a company performs a stock 
inversions, shareholders can be subject to large capital gains taxes. The U.S. tax code requires the 
shareholders to pay capital gains taxes on the stock when the inversion takes place on any gains from 
when the stock was originally purchased to when the stock is changed over to another company via 
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inversion. Similarly with an asset inversion, the company must pay capital gains taxes on the 
appreciation of assets that become a part of the new company, sometimes created a large cost for the 
company depending on the appreciation of the assets. 
3 Literature Review  
 This thesis aims to closely examine the recent trend of tax inversions, with specific focus on the 
recent trend of pharmaceutical companies moving headquarters away from the United States and to 
different countries, primarily Ireland. There has been a fair amount of research surrounding general 
research on tax inversions, such as what a tax inversion is and how a company performs an inversion. 
Little research looks at specific industries engaging in such activity, which is what this thesis intends to 
address.  
 The prior research sets the foundation for the question that will later be addressed in this paper. 
It is important to first understand the motivations for an inversions. This literature review will also 
outline corporate tax laws for two different tax systems, the territorial system and the worldwide 
system, which have a large impact of firm’s decisions of where to invert. Finally in the next sections, this 
paper will take this one step further and attempt to answer why the pharmaceutical industry in 
particular has been in the news so often recently for engaging in tax inversions. The following sections 
outline the two major tax systems and how they tax foreign income at the corporate level. The 
comparison uses a hypothetical example using the different treatments of Microsoft’s income in 
Switzerland and the United States. 
3.1 Territorial vs. Worldwide Tax System 
When a company earns profits in a certain country, that country will charge taxes on the profit 
that is earned. For companies that only operate in one country, the tax paid is relatively straightforward, 
the company will pay the tax rate that the country has mandated. For multinationals on the other hand, 
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the taxes paid are derived from two different sources. If a multinational company earns profits in a 
different country than where it is located (e.g. Microsoft, a United States company, sells software in 
Switzerland), it will first and foremost pay taxes where the profit is earned (in the example, Switzerland). 
The company will also pay taxes in their home country (in the example, the United States). Different 
countries have different systems for taxing corporate income earned in foreign countries, but 28 of 34 of 
the G8 member countries employ a territorial tax system whereas the other six use a worldwide system 
(Dittmer).   
Territorial Tax System    
Under the territorial tax system, a multinational firm will only be taxed by the country where it 
makes the profit. Using the Microsoft example, when Microsoft sells software in Switzerland, it is taxed 
on the profits of the sale by the Swiss government at the Swiss corporate tax rate. Hypothetically if the 
United States uses a territorial tax system, when Microsoft brings the profit generated in Switzerland, 
the United States government will not additionally tax any profits (Desai, Hines, 5). It does not matter in 
a territorial tax system where the company is headquartered, only where the company earns profits. 
The company will be taxed following the rules set out by the specific country where revenue is earned, 
not by the rules where the company is physically headquartered.   
Worldwide Tax System 
In the worldwide tax system, a multinational will be taxed both by the country where they 
create profit at the time of the profit is realized, and by the home country when the profits are brought 
back. In the Microsoft example, Microsoft will be taxed by Switzerland at the Swiss corporate tax rate 
when they sell software. Hypothetically if the United States uses a worldwide tax system, Microsoft will 
be taxed by the United States when they bring back profit. Microsoft will receive a tax credit on the tax 
expense paid to the Swiss government, but will still have to pay taxes to the United States. If the Swiss 
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tax rate were 20%, and the United States tax rate were 35%, Microsoft would have to pay 20% to the 
Swiss government and would still be responsible for paying an additional 15% to the United States 
government. The purpose of this tax system is to tax all companies the same amount, regardless of 
where profit is being generated (Desai, Hines).  
In reality, companies use a combination of the systems, but as stated above, a heavy majority 
use a system more resembling a territorial tax system. The United States is one of few countries to still 
use a worldwide tax system, creating an incentive for companies to move overseas to countries that use 
a territorial tax system in order to save on taxes brought back to the home country of the company. 
Using Microsoft once again, if Microsoft were legally listed in England, a country that uses the territorial 
tax system, they would not have to pay as much additional taxes on the profit generated outside of 
England. In companies that create a large amount of profit outside of their home company, these 
differences in tax systems can lead to a strong desire to relocate to a more favorable tax system. This is 
where a tax inversion comes into play. Companies are willing to engage in a merger or acquisition at a 
premium in order to restructure their taxes.  
3.2 Motivation for inversion 
There are costs associated with an inversion, just as with any merger or acquisition, such as the 
cost of purchasing controlling stake in the company. Mergers can be very expensive for a company, but 
many U.S. based companies have recently purchased foreign companies at a premium. U.S. companies 
such as Activis, Horizon Pharma, and Abbvie have recently paid, or proposed to pay more than the 
suggested value of foreign companies (Schmidt, Bates, Paravano, 4). There must be then a motivation 
for companies to pay a high price to take over a foreign company. As the name suggests, tax inversions 
boil down to taxes and the benefits of being legally registered as a company in a certain country over 
10 
 
another country. The main tax benefit lies in the income that a company earns and how that income is 
taxed.  
Location is beneficial for a company’s tax rates is two ways. The first is the most obvious and 
most important, the rate at which the country taxes a company. The United States has a high corporate 
tax rate in comparison to many other countries. Some countries, such as the Bahamas, Bermuda and the 
Cayman Islands have zero corporate tax. Strictly from a corporation’s perspective, it is cheaper to be 
located in a country with lower corporate tax rates. The second form of a beneficial location would be 
when a corporation is located in a country with a territorial tax rate. Under the territorial system, 
companies are only taxed where they earn profit, and not where they are formally headquartered. 
Though there are also other forms of tax benefits for multinational companies, such as different 
treatment of capital gains, the tax benefits on profits earned tends to be the key driver of companies 
wanting to engage in a tax inversion (Desai, Hines, 421). Multinationals spend a large amount of time 
and money creating ways to lower their effective tax rate by placing assets and incomes in different 
countries. Despite these efforts, research has shown that the location of the parent company has the 
largest effect of the effective tax rate of a company, further driving importance of the location of the 
parent company (Markle, Shackleford). A recent study showed that a one point reduction in corporate 
tax rate has been associated with a 1.2% increase in firm value, further showing the importance of the 
tax rate to a company (Bennedsen, Zeume, 3). 
Aside from the tax benefits mentioned, another large advantage to an inversion is that 
inversions allow companies to use the cash that is held overseas. Companies are only required to pay 
taxes to the United Sates government on foreign income when the income is brought back to the United 
States. In order to try to save money of tax expense, many companies will keep large amounts of cash in 
other countries as to avoid paying taxes when they bring the cash back to the United States. In addition 
to simply keeping cash in other countries, companies invest more heavily in other countries as a form of 
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keeping cash abroad and avoiding any possibly tax expenses.  When a company inverts, the cash can be 
brought back to the firm’s headquarters where presumably, the new location of the firm will not tax 
cash brought back from foreign countries. Having the option to bring back cash can be more important 
for companies that use a large amount of cash in their business, for anything from product research and 
development to expensive manufacturing (Bennedsen, Zeume, 2-5). 
3.3 Conclusions 
There has been a research about tax inversions and the impact on the firm in the ways of tax 
benefits. There has recently been a lot of attention to these deals in the news and in the government. It 
is important to note the difference between a tax inversion and any other merger or acquisition. The key 
distinguishing factor is the relocation of the parent company. It is assumed that the main motivation for 
companies to perform an inversion is the tax benefits from being legally headquartered in another 
country. To this point, the literature has only looked at inversions broadly. In the following sections this 
paper will identify factors where inversions could be popular in terms of opportunities for tax benefits. 
Then, the paper will move on to examine the differences between two different industries to examine 
traits of a business that may make it more likely to engage in a tax inversion than other suitable 
industries. 
4. Methodology 
This thesis will use a case study to analyze the recent trend of pharmaceutical companies 
moving overseas. Previous literature has shown that companies are influenced mainly by tax 
motivations when making a decision to perform an inversion. When analyzing the companies within the 
last three years, a startling majority of companies that have either completed or are in the process of 
completing a tax inversion have been within the pharmaceutical industry. Many companies across a 
variety of industries could find potential tax breaks by looking to move headquarters to different 
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countries, yet, by an overwhelming majority, pharma companies have been leading the charge. Six large 
deals in the pharmaceutical industry have headlined the trend of tax inversions in the media. By 
analyzing a number of drivers, the paper will attempt to create a rationale for why the pharma industry, 
in comparison to other similar industries, is leading the charge of the recent trend of tax inversions. This 
paper hypothesizes that the trend is fueled by one or more of the following drivers; a) industry origins b) 
revenue structures c) ownership structures and d) legal factors. In order to assess these drivers’ 
implications, there needs to be a comparable industry to show differences in these drivers. The Software 
industry creates a suitable comparison due to its similarity in industry size, industry margins, 
globalization and research and development costs. This section outlines the method of data collection 
and explain my rationale for using a case study to examine this trend. The software industry includes 
such companies as Microsoft and Oracle. 
4.1 Software Industry Comparison 
The software industry is a fair comparison based on four different factors, industry size, profit 
margins, globalization, and R&D Spending. The table outlines the factors that make technology a 
suitable industry comparison. The data collected looks at industry facts from IBIS world, which 
categorizes industries based on the North American Industry Classification System (NAICS). All data 
collected encompasses all companies that fall under the classifications for each industry. It is important 
to note that these companies are similar in regards to motivations for tax inversions. The similarities are 
drawn in regards to what would make a company consider performing an inversion. Below the table 
each factor is explained further and outlines the importance of the specific factor in regards to an 
inversion. 
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Factor Comparison Table 
Factors Pharma Industry Software Industry 
Industry Size Revenue: $163.5 Billion 
 
Number of Companies: 1,566 
Revenue: $196.2 Billion 
 
Number of Companies: 5,196 
Profit Margins Total Industry Margin: High – 33.4 
Billion.  
Total Industry Margin: High – 9.2 Billion. 
This margin percentage can be as high 
as 40% in large companies 
Globalization Globalization in this industry is high and 
the trend is increasing (IBIS World) 
Globalization in this industry is high and 
the trend is increasing (IBIS World) 
R&D Spending 19% of total Revenues 12% of total Revenues 
The data for this table is collected from various industry reports on the IBIS World Database 
 
Industry Size 
The Industry size has two components that are important to compare. The first is the overall 
number of companies. Both industries have thousands of companies in their industry. This means that 
inevitably there are smaller companies in the industry which are much easier to take over than a larger 
company. Past research has shown that the probability of a takeover decreases with firm size (Powell). 
This suggests that smaller firms are more likely to be acquired. Intuitively, this makes sense, as smaller 
companies will have less assets or shares to acquire, reducing the amount of capital needed by a larger 
firm to perform a takeover. One key factor to being able to perform an inversion is having a company to 
take over. The government has made regulations banning takeovers such as the McDermott takeover, 
where a subsidiary is created in another country with the purpose of purchasing the larger parent 
company in order to change headquarters. The large amount of companies in both industries suggests 
that both industries have potential takeover targets. The second size number is the overall revenue of 
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the industry. Both industries recognize large amount of revenues suggesting a large customer base. The 
industry sizes are similar when compared to other industries.  
Profit Margins  
The profit margins are the most important factor in relation to motivation for tax inversions. 
When companies have larger profit margins, it is much more likely that the company will also have 
larger tax expenses. With these higher tax expenses, companies have an increased desire to find ways to 
save on tax expenses, such as a tax inversion. Industries with smaller margins have less motivation to 
find ways to reduce tax rates. Higher margin industries are more willing to spend money to find lower 
tax rates and lower tax expenses. As discussed previously, lowering tax rates is the most important 
motive for companies to propose an inversion. When margins are higher, the company has increased 
motivation, making high profit industries likely to invert. As both the pharmaceutical industry and the 
software have much higher than average profit margins, both are industries that may look to be in low 
tax locations, making both comparable industries. 
Globalization 
Many companies in this industry recognize revenue and operations around the world. Both 
pharmaceuticals and software are products that are used around the world regardless of culture or 
geographic location meaning that it is not vitally important for companies to be headquartered in the 
area where a majority of revenues are recognized, as both industries have multinationals that will sell 
around the world regardless of where headquarters are located. The second important aspect of 
globalization is the potential takeover targets. In addition to small companies, there need to be 
companies in countries with favorable tax laws. If all companies are in the same country, they are all 
under the same tax regulations. The global industry provides more options for companies to find a 
takeover target in a favorable location. Considering both companies have a very global presence, not 
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only in the location of companies, but where the industries generate revenues, the software and 
pharmaceutical industries are a fair comparison. 
Research and Development Expenses 
 Both industries are heavily driven by research and development. The software industry does not 
make a physical product with the exception of a CD or other device to hold the software. Both 
companies require large amounts of investment into research and development programs. As discussed 
earlier, one advantage of being located in a country using the territorial system is freedom to bring cash 
back to the company headquarters without being subject to tax laws in the domiciled country. Tax 
inversions allow companies with large amount of research and development costs to repatriate earnings 
and gives freedom for companies to use cash where it is needed. Considering both industries have large 
research and development costs, the freedom to be able to bring cash back to the company’s 
headquarters and reinvest money freely is a large advantage. Though the pharmaceutical industry has a 
higher percentage of revenues going to research and development, a high percentage of wages paid to 
workers in the software industry are paid to individuals that work on research and development. These 
costs are not directly expensed as research and development. The high costs as a percentage of revenue 
in both industries make the two a fair comparison. 
4.2 Motivation for Methodology 
A case study is the most appropriate way to analyze this situation. This method is the most 
effective way to analyze multiple factors that are both quantitative, but also strongly qualitative in 
nature. As there is little statistical comparison that can be drawn between such qualitative factors, a 
case study allows for a unique way to assess the question by comparing a similar industry. With the 
small sample size of looking at two different industries, statistical tests would be unreliable and not give 
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a clear picture of the situation. Though multiple industries can be chosen that could draw a comparison, 
the software industry draws the best comparison as outlined in section 4.1 above. 
Through looking at the results of the case study, each factor can be individually assessed and a 
conclusion can be made about the influence or importance of each driver. The case study aims to 
highlight major differences in a variety of data. This study will look to explain any differences and 
examine how the driver would affect one company moving overseas. The next section will not only 
analyze differences in industries with regards to the drivers, but it will also explain the importance of 
each driver as a decision maker in a tax inversion deal. It may be found that more than one driver 
influences firms decision making process. It may also be found that no drivers can be found and 
inversions have become a “keeping up with the Jones’” phenomenon. This phenomenon is an idea that 
companies are only engaging in inversions in order to follow their competitor’s actions. This idea will be 
discussed further in the data analysis and results section.  
Key Drivers Used 
 The following sections discuss the drivers examined in the case study. Each section explains 
what is found in each section of the case study and highlights the potential importance that each driver 
could have on the decision making process of the firm. These drivers are derived based on past research 
combined with potential tax inversion benefits. 
Revenue Structure  
 The revenue structure examines where the cash flows for the industry are being generated. The 
total revenue of the 25 largest companies in the industry are added together and compared. The data 
shows differences in the total revenue of these 25 countries that is being generated inside the United 
States instead of outside of the United States. Only the 25 largest companies are examined in this case 
study. Previous literature has shown that larger companies are more likely to be companies who are 
17 
 
engaging in takeovers (Powell, 50). The smaller the company, the more likely that the company will be 
bought out by another company. Given that the larger companies are more likely to be engaging in 
takeovers, only these companies are compared. The importance behind the revenue structure lies in the 
fact that if a large amount of revenues are generated outside of the United States, more taxes will be 
paid if these revenues are brought back to the United States through the tax methods discussed earlier 
in this paper. If a United States company is making a majority of revenues outside of the country, there 
will be more incentive to find ways to reduce the tax expense from these foreign revenues, such as an 
inversion. The amount of revenue gained inside of the United States has less of an effect, as taxes on 
foreign revenues are based on the country where the revenue is recognized. No matter the firm’s 
location, the revenue generated inside the United States will be taxed at the same rates. This means 
that revenue generated inside the United States by a U.S. company will be taxed at the same amount as 
revenue generated inside the United States by a company from Ireland. When companies located 
outside of the United States gain a large amount of revenue in foreign countries and bring the revenues 
back to the company’s headquarters, no additional taxes are paid upon repatriation. Changing a firm’s 
headquarters through an inversion provides a company a way to avoid paying repatriation taxes, 
assuming the company is located in a country using the territorial tax system. Therefore, more revenue 
generated outside of United States gives companies more incentive to find ways to reduce tax expenses 
on money generated outside of the United States.  
Ownership Structure 
 This area very simply looks are whether most of the industry is financed publically or privately. 
When companies are financed publically, the company is at the discretion of the shareholders, 
compared to private companies whose decisions are driven by the few owners of the company. Public 
companies are constantly under scrutiny of their shareholders. If shareholders see rivals in the industry 
moving overseas for tax purposes, they may wonder why their company is not moving overseas. Past 
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research also gives a glimpse into the differences in takeover behavior between public and private 
ownership. Private companies are generally undervalued when compared to public companies, making 
private companies cheaper to acquire (Bugeja, Sinelnikov, 406). If the company is largely undervalued, 
the market believes it is worth less than it may actually be worth. If private companies can be bought at 
a cheaper price, then an industry with more private companies may be more prone to buyouts as 
companies can find god deals on private companies. The data compares private companies to public 
companies in each industry. Past research suggests the industry with more private companies would 
have more companies that are undervalued and therefore could be bought out for a good price. In 
addition to the value of the company, private companies are less independent than public companies 
(Bugeja, Sinelnikov). Prior literature suggests that independence can be a factor when examining the 
company purchasing a takeover target. Many times private companies have alternative motives for 
engaging in a takeover. Public companies tend to have a specific goal in mind when evaluating a 
takeover proposition. Generally, this goal is to the sole advantage of the shareholders, the owners of the 
company. When examining takeovers as part of tax inversions, the main goal of a public company 
engaging in a tax inversion is to lower tax expenses. After examining these two aspects of ownership, an 
industry with large public companies with a singular goal of lowering tax expenses may be more likely to 
engage in inversions. At the same time, industries with smaller private companies that may be 
undervalued may be more likely to have inversions due to price of buying out smaller companies. 
Industry Origins 
 The industry origin driver is broken into two parts. The first part examines the location of all 
firms in the industry to gain an idea of where companies within each industry are located. The study first 
examines where all publically owned companies within the industry are located. The data lists 
companies that are inside the United States and compares them to companies outside of the United 
States. It is important to have an understanding of firm location because if more companies are located 
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inside the United States or countries with higher tax rates, there are less targets for potential takeovers 
in the industry when compared to an industry where many companies are located outside of the United 
States.  The second part of the data looks more specifically at the 25 largest companies in the industry. 
These 25 largest are determined based on revenues generated in 2014. The study again focuses on the 
25 largest companies as the companies most likely poised and able to perform a takeover. It is 
important to note for the pharmaceutical industry that many of the large players have engaged in a tax 
inversion or takeover which will affect the data. For this reason, companies that have successfully 
performed an inversion within the past 3 years will be included in the original location of the firm, so as 
to eliminate the dynamic shift in the pharmaceutical industry. The origins of the industry are important 
so far as potential takeover targets. If a majority of the companies are inside of the United States, large 
American corporations will have less targets to take over a company located in a more favorable tax 
location. 
Legal Factors 
 The last driver is the legal factors upon each industry. A closer examination of the legal 
environment around the company gives a picture of how the company is expected to act. For the 
purpose of this study, these legal factors exclude any tax laws. The tax effects of regulations are already 
assumed to be accounted for in the company’s initial decision to consider an inversion. This section 
looks at regulations that governments have in place that may impact the industry beyond tax impacts. 
For this specific study, the data examined outlines main legal concerns for the largest companies in each 
industry as outlined in annual reports, as well as federal laws surrounding both pharmaceutical 
regulation and software regulation. If a company can find a country where legal factors are favorable, 
meaning there are less restrictive laws, a company may be more inclined to move.  
4.3 Data Collection 
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In order to analyze each driver, a wide range of data was collected. Company specific data, 
industry data, and government data is examined in order to have a complete look at each driver 
involved. The table below outlines what data was collected for each key driver and what source was 
used to collect the data. The data from varying sources addresses each factor individually and allows 
assessment of the importance of each driver in the decision making process of a tax inversion.  
Data Collected Table 
Key Driver Data Collected Source of Data 
Revenue 
Structure 
 Where revenue is generated 
domestically vs. internationally 
 
 Annual Reports of largest 25 
companies in the industry – 
income statements 
 S&P IQ Capital Net Advantage 
Databases 
 
Ownership 
Structure 
 How companies are financed through 
equity, either through private 
ownership or public ownership 
 Listings on stock exchanges 
 Stock Exchange listings 
 S&P IQ Capital Net Advantage 
Databases 
 Company Reports – private 
websites of companies 
 Annual Reports of public 
companies 
 
Industry 
Origins 
 Company headquarters locations for 
top companies 
 Company headquarter locations for 
all publically listed companies 
 Annual reports 
 S&P Company Listings 
 NAICS Industry Classifications 
 S&P IQ Capital Net Advantage 
Databases 
 
Legal Factors  Regulatory factors on a particular 
industry 
 The role the government plays in the 
industry and how much control 
government has 
 U.S. FDA website 
 U.S. IRA tax regulations 
 Annual Reports for largest 25 
companies  
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4.4 Limitations and Strengths of Methodology 
The main strength of the methodology is the use of a case study. A case study allows the 
question to address a variety of data for the two specific industries. The software industry has many of 
the same characteristics as the pharmaceutical industry in a couple key aspects and provides a 
reasonable comparison. By using a case study with a comparable industry, this paper is able to isolate 
potential drivers that may influence firm’s decision making with regards to tax inversions. An important 
assumption is that the two industries are similar enough to compare. The justifications in the previous 
section outline why the two industries are selected. 
 The pharmaceutical industry is very unique, in terms of the fact that there are around fifteen 
companies that dominate the industry around the world. This is tough to do in many industries, but as 
pharmaceuticals are a product that are going to be used, regardless of language, culture (excluding 
some religions), or geographic locations, companies are able to dominate markets around the world 
with one large parent company. Thus, finding a comparison can be difficult. This paper fails to address 
other industries that may also have a fair comparison such as size, margins and globalizations, but the 
software industry has just reasoning for why it was chosen.  
Another limitation is looking at the industry as a whole compared to companies individually. The 
software industry has more companies overall that are smaller and may not have the capital necessary 
to perform a takeover of a foreign company, but it is important to recognize that there are many large 
companies in the industry such as Oracle and Microsoft who are not engaging in the same tax inversion 
transactions as the pharmaceutical industries is with similarly sized companies. By not assessing 
individual companies and only looking at the industry, some information or factors may be missed by 
not looking closer at individual company statistics. 
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One further note is that the data collected adhered to companies listed by specific NAICS codes. For the 
software industry, the industry classification system only put companies that generate the majority of 
revenues from software as part of the software industry. For the technology industry, this can cause a 
skew in the data. IBM is a large company that generates a lot of software revenue around the world. 
IBM’s main source of revenue is not software however, so IBM is not included in this case study. As IBM 
generates a lot of revenues around the world, this could have potential impacts on the data collected. 
A final limitation is the use of a case study is an inability to examine how these drivers work 
together. A case study does a good job of examining each variable, but does not allow for two or three 
variables to work together. In this study for example, the case study separates ownership structure and 
industry origin, allowing an examination of each individually. The study is limited in its ability to compare 
how ownership structure in different industry origins for a specific industry relate to ownership 
structure in different industry origins for another specific industry. This limits to effectiveness of the 
study in terms of finding an overall structure for companies engaging in tax inversions, but rather excels 
at pointing out individual characteristics of industries. 
5. Results 
 After data was collected from a variety of sources, it was compared across industries. Each 
driver was examined as outlined above in the methodology section and the results are displayed below 
in the Drivers Results Table. Assessing the driver’s importance was based on the differences in the data 
across the industry. For each factor, a different set of data is used to derive a set of differences observed 
between the two industries. From this point, the data is compared based on the potential impacts a tax 
inversion would have on each driver. For the revenue structure, the majority, almost 59%, of revenues 
for the pharma industry were generated internationally, defined as sales outside of the United States. 
The software industry on the other hand had just under half, or 49% of its revenues generated 
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internationally. This lead to an “important” rating being assigned to this factor, as a majority of revenues 
in the pharma industry are generated outside the United States, while a minority of revenues in the 
software industry are generated outside the United States. A similar rationale is applied to the industry 
origins driver. The pharmaceutical industry has a healthy majority of companies, 60%, headquartered 
outside of the United States, whereas the software industry only has 48% headquartered outside of the 
United States. The ownership structure sees a large difference in percentages of public ownership 
compared to private ownership across the industries. The pharmaceutical industry has more than 3 
times the percentage of publically owned companies, at 32%, than software industry, where only 10% 
on companies within the industry are publically owned. This leads to the driver being deemed highly 
important given the large difference in percentages. The legal factors do not affect the industries 
location very much, as both need to comply with the regulations of the country where business is done 
as opposed to where the company is headquartered. After review of the legal factors, this driver is not 
important for firm’s decision to perform a tax inversion. The table on the following page summarizes the 
main findings across each industry.  
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Driver Results Table 
 Pharma Industry Software Industry Key Driver Importance 
Revenue Structure 
The revenue structure of a 
company plays a large role 
in the amount of taxes 
paid. If companies are 
incorporated in the U.S., 
they pay more of the high 
U.S. corporate tax rates. 
 
When examining the 25 largest publically traded 
companies in the industry, the total revenue 
generated for 2014 was about $572 billion 
dollars. 
 
Of the $572 billion, $237 billion, or 41.20% of 
revenues were generated in the United States 
while $336 billion, or 58.80% were generated 
internationally 
When examining the 25 largest publically 
traded companies in the industry, the total 
revenue generated for 2014 was about $178 
billion dollars.  
 
Of the $178 billion, $90 billion, or 50.78% of 
revenues were generated in the United States, 
while $88 billion, or 49.23% were generated 
internationally. 
Somewhat important. 
Ownership Structure 
Public Companies are 
defined here as listed on 
any stock exchange 
market. Public companies 
must keep the desires of 
shareholders in mind when 
making decisions. 
Of the 3,270 companies assigned to the 
Pharmaceutical manufacturing industry 
classification code, there are 1,063 that are listed 
on a public exchange and have total revenues of 
greater than zero. 
 
32.5% of all companies within the industry are 
public. 
 
Of the 5,166 companies assigned to the 
Software Publishing industry classification 
code, there are 538 companies that are listed 
on a public exchange and that have total 
revenues greater than zero. 
 
10.4% of all companies within the industry are 
public. 
Highly Important. 
Industry Origins 
Many industries tend to 
move to clusters globally, 
and can tend to feel 
pressure to be located near 
competitors. 
 
Of the 1,063 publically listed companies in the 
industry with revenue greater than zero, 426, or 
41.01% of companies are headquartered in the 
United States. 
 
637, or 59.99% of companies are headquartered 
internationally. 
Of the 538 publically listed companies in the 
industry that have a revenue of greater than 
zero, 283, or 52.6% of companies are 
headquartered in the United States. 
 
255, or 47.4% of these companies are 
headquartered internationally.  
Somewhat important. 
Legislation  
The more legislation a 
company faces, the more 
conscious it must be of 
every aspect of the 
business, usually leading to 
incurring more expenses. 
Food and Drug Administration, has stringent laws 
on pricing, testing, manufacturing and labeling. 
All companies in the industry face FDA legislation 
for products sold in U.S. 
 
Most other countries provide legal requirements 
for pricing and patents, aiming at making drugs 
low cost. 
United States anti-trust laws often face the 
software industry, especially for the larger 
players.  
 
EU closely scrutinizes software releases, often 
causing delays and or cancellation in release in 
software. 
Not important. 
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5.1 Discussion of Results 
 The following sections go into more detail of each driver and the data collected. After analyzing 
data, the results are compared with expectations for each driver. Finally, a brief discussion of possible 
differences in expectations and what the data provided follows. 
Revenue Structure 
 According to the National Tax Foundation, in 2010, the effective tax rate for corporations 
earning income outside of the United States was around 27%. For the largest corporations, the tax rate 
in 2010 for the United States was 35%. This means that corporations are paying an excess 8% on 
earnings outside of the United States when revenue are repatriated. If this 8% rate were applied to the 
entire industry, over $25 billion dollars of tax was paid to the United States government on earnings in 
foreign countries for the pharmaceutical industry. While this number is most likely exaggerated, as these 
are average industry rates and not all earnings are brought back to the United States, this is a large 
number that companies could potentially be saving. In comparison, this same roughly estimated figure is 
only $7 billion for the software industry. If the software industry as a whole earned as much as the 
pharmaceutical industry, the more realistic differences in taxes paid of foreign earnings would be closer 
to $2 billion less. These numbers are loose estimates, but show how important the tax system can be for 
these industries.  
When examining the data collected for the 25 largest companies in each industry, the 
pharmaceutical industry gains 58% of revenues outside of the United States compared to the software 
industry, who earns only 49%. These are not unexpected results given the trend of inversions in the 
United States. The pharmaceutical industry earns more revenues outside of the United States, and 
therefore are more eager to look for ways to reduce its effective tax rates through tax inversions. The 
unexpected aspect of these results are to look the software industries potential benefits of inversions. 
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Like the pharma industry, the software industry generates a large amount of revenue internationally, 
which after an inversion could be taxed at a more favorable rate. From this data, there seems to be a 
threshold of revenue structure where the benefit of an inversion outweighs the cost. As this study 
focuses on the industry as a whole, this threshold cannot be reasonably deducted, but the data would 
suggest that a closer look at a company’s revenue structure, specifically where revenues are generated 
can impact a firm’s decision to perform a tax inversion. 
Ownership Structure 
 Based on the assumption from past research that private companies are undervalued when 
compared to public companies, the data on ownership structure is somewhat counterintuitive. The 
software industry has almost 90% of companies private, compared to closer to 68% private companies 
in the pharma industry. This would suggest that there are many companies in the software industry that 
may be undervalued and therefore could have potential takeover targets. However, out of the top 25 
largest companies in terms of revenues, the pharmaceutical industry has more companies that have 
public ownership (or a form of public ownership, as in the case of a few European pharmaceutical 
companies). 22 of the 25 largest software companies examined in this case study are public, while 24 of 
the 25 largest pharmaceutical companies examined in this study have some form of public ownership 
(S&P data). Based on the prior literature discussed, the data supports the idea that public companies are 
more likely to engage in a takeover with a singular goal in mind, which is this case is to lower tax 
expenses. Having more public companies also means that more companies in the pharmaceutical 
industry are influenced by shareholders, pressuring executives to create value for shareholders. For the 
purpose of this case study, the value is derived by lowering of the effective tax rates by relocating 
headquarters. As previous stated, lowering effective tax rates by just one percent has shown increased 
in firm value of 1.2 percent (Bennedsen, Zuome, 3). Based on the large differences in ownership 
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structure between the two industries, the data suggests that ownership structure has important 
influence on an industries decision in regards to tax inversions. 
Industry Origins 
 The data collected in the industry origins section points to a few interesting results. The first 
result is the overall, the pharmaceutical industry is much more diverse in terms of firm location. 60% of 
publically listed companies in the pharmaceutical industry are located outside of the United States while 
only 47% of companies within the software industry are located outside of the United States. This 
immediately gives companies within the pharma industry more companies outside of the United States 
in potentially tax favorable locations. More companies outside of the United States leads to a larger 
amount of potential takeover targets within the pharma industry.  
 Another aspect of industry origins is the idea of industry clusters. Before 2012 and the wave of 
pharmaceutical companies moving to Ireland, there was no real cluster of companies within the 
pharmaceutical industry. The largest 25 companies in the industry today are spread all around the 
world. In comparison, only 2 of the largest 25 software companies examined in this paper are located 
outside of the United States. Silicon Valley is a large cluster of technology firms that provides numerous 
advantages for companies within technology industries (Engel, 37). The lack of any apparent cluster in 
the pharmaceutical industry allows companies within this industry to be located around the world and 
have less of a concern of being far away from the advantages of a cluster. The software industry does 
not have the same freedom. Both aspects of firm location seem to suggest that a more global industry 
makes companies within that industry less concerned with location making relocation due to an 
inversion less of a concern. 
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Legislation 
 The data shows that legislation is of little importance on firm location and would not impact a 
firm’s decision to engage in an inversion. Much of the legislation in both industries is geared towards 
where the product is used as opposed to where the product is created. This devalues any firm’s decision 
to change location, as no matter where the headquarters are located, the firm must always adhere to 
the laws of the country where the product is used or consumed. Legislation, excluding tax laws, has very 
little to no impact to further a company’s decision to perform a tax inversion. 
6. Conclusion 
 The results show a level of importance on each of the four drivers analyzed for the hypothesis 
that revenue structure, ownership structure, industry origins and legislation create incentives for 
pharmaceutical companies to engage in a tax inversion. Drivers were examined through a variety of 
mainly qualitative data sources in order to analyze the differences across industries of each driver. These 
drivers were chosen based on past research of inversions in addition to the potential tax benefits of 
inversions and how the driver affects these benefits. There are other industries that could have been a 
suitable comparison based on the globalization of the business and the profit margins, but as discussed, 
the software industry provides a comparison with similar characteristics in many regards.  
 These drivers can be used more generally to describe industries that may want to consider an 
inversion. For example, companies in an industry where clusters of other companies may be located 
may be tempted to invert and be closer to the cluster, where a workforce and infrastructure are in place 
to support the industry. This is not the case with regards to the pharmaceutical industry as no cluster is 
apparent, but the software industry has a cluster inside the United States which discourages software 
companies from relocated away from the United States. 
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 These results match expectations for the most part. For the revenue structure in particular, it 
makes intuitive sense that if a company were to gain more revenues in other countries than the United 
States, then this would lead to more of an incentive to move to a country where tax rates are lower and 
where the company does not need to pay domestic taxes on foreign revenue. What is interesting about 
the revenue structure is the size of the revenues. For the software industry, almost 50% of revenues 
overseas still would seem an important driver to move overseas, yet this does not occur. This could 
either suggest that the other drivers tie into the decision, making tax implications not necessarily the 
only driver that firms look at. This could also suggest that the cost of inverting is just too high for the 
money saved in the industry. It is possible that the almost 60% of revenues from the pharmaceutical 
industry generated in foreign countries is high enough for companies to take note and act to try to lower 
that expense at that point. It was unexpected to find such a difference in the amount of public vs. 
private companies in the industries. The pharmaceutical industry has almost 3 times more of the 
percentage of publically owned companies than the software. This may account for the massive amount 
of media attention these deals get, as the media will report on the news that will affect investors of the 
companies.  
 The one driver that was expected to be most important, as yet was not important at all was the 
legal environment. As tax is part of the legal environment, all companies will be under the same scrutiny 
within countries for the tax part. However, the legal environment is also similar for both industries, and 
could be said about most industries in the United States, especially within consumer products. The 
government were the product is being sold is going to have the last say on the good sold and therefore 
the home of the country is not important. The results did show however that the software companies 
may be under more scrutiny in other countries than the United States. This would suggest that the legal 
factors may be a driver for software companies to stay in the Unites States instead of leave.  
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 Overall, 3 of the 4 drivers showed differences in the industries and showed that these may be 
more important factors than simply the profits of the companies and the globalization of the company. 
The revenue and ownership structures as well as the industry origins had importance in the decision 
while the legal factors did not. Though this paper did not address it, the results hint that these factors 
may be intertwined and that more than one would be necessary for a company to consider an inversion. 
 One factor that has not been addressed is that of a game of follow the leader. If one company 
sees success from engaging in an inversion, other companies may be inclined to follow suit. After a 
successful inversion from a pharmaceutical company, others in the industry may feel that they need to 
keep up with the competition and do not want to move slowly in order to stay competitive. This 
phenomenon may be further driven with that large amount of public companies within the 
pharmaceutical industry. Shareholders of public companies may have further influence as they expect 
their company to follow suit with competitors. Software companies however may not feel the pressure 
to act as they are not in competition with the pharmaceutical companies. This is difficult to identify 
without having access to the decision makers in the companies that are performing the tax inversions.  
 The next step in this line of research is to extend the same case study to look at the countries 
that companies invert to. Why is Ireland the feature destination for so many companies lately? Many 
countries have similar tax systems as Ireland, so factors such as education, available capital, and 
resources may come into play.  
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